Principal Investigator
Macarena De La Fuente
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20230388
Clinical Trial Summary
A Phase 1 and Randomized Phase 2 Trial of Selinexor and Temozolomide in Recurrent Glioblastoma
Phase
Phase I/II
Funding Agency/Sponsor
National Cooperative Group
Disease
Neurological Cancer
Contact Information
Phone Number
+1 (305) 2437261